Vivici

Founded in 2023 and based at the Biotech Campus in Delft, Vivici is a B2B ingredients company that makes animal-free dairy proteins using precision fermentation. It was launched as a venture backed by nutrition-and-health multinational dsm-firmenich and dairy cooperative Fonterra, which had collaborated on fermentation-derived dairy proteins. Its first commercial ingredient, Vivitein BLG, is an isolated whey protein (beta-lactoglobulin) made without cows, sold under the Vivitein protein platform. In early 2025 Vivici secured a €32.5 million (about $33.7 million) Series A led by APG (on behalf of pension fund ABP) and Invest-NL, with participation from InnovationQuarter and existing shareholders dsm-firmenich and Fonterra, to expand internationally and add manufacturing capacity. Stephan van Sint Fiet is CEO.